315 related articles for article (PubMed ID: 9126039)
21. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
23. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
[TBL] [Abstract][Full Text] [Related]
24. Gliosarcoma: clinical experiences and additional information with MR spectroscopy.
Buhl R; Stark AM; Hugo HH; Rohr A; Mehdorn HM
Neurol Res; 2009 Oct; 31(8):873-7. PubMed ID: 19215667
[TBL] [Abstract][Full Text] [Related]
25. Primary gliosarcoma of the brain: radiologic and histopathologic features.
Romero-Rojas AE; Diaz-Perez JA; Ariza-Serrano LM; Amaro D; Lozano-Castillo A
Neuroradiol J; 2013 Dec; 26(6):639-48. PubMed ID: 24355182
[TBL] [Abstract][Full Text] [Related]
26. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
27. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
28. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
29. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
30. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
31. Glioblastoma multiforme with long term survival.
Deb P; Sharma MC; Mahapatra AK; Agarwal D; Sarkar C
Neurol India; 2005 Sep; 53(3):329-32. PubMed ID: 16230803
[TBL] [Abstract][Full Text] [Related]
32. Extrapleural solitary fibrous tumor: a report of seven cases.
Fukunaga M; Naganuma H; Nikaido T; Harada T; Ushigome S
Mod Pathol; 1997 May; 10(5):443-50. PubMed ID: 9160308
[TBL] [Abstract][Full Text] [Related]
33. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years.
Kumar P; Singh S; Kumar P; Krishnani N; Datta NR
J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388
[TBL] [Abstract][Full Text] [Related]
34. A clinico-pathological study of 29 cases of gliosarcoma with special reference to two unique variants.
Sarkar C; Sharma MC; Sudha K; Gaikwad S; Varma A
Indian J Med Res; 1997 Sep; 106():229-35. PubMed ID: 9378529
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
36. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases.
Scheithauer BW; Erdogan S; Rodriguez FJ; Burger PC; Woodruff JM; Kros JM; Gokden M; Spinner RJ
Am J Surg Pathol; 2009 Mar; 33(3):325-38. PubMed ID: 19065105
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma.
Kleer CG; Giordano TJ; Merino MJ
Mod Pathol; 2000 Jul; 13(7):742-6. PubMed ID: 10912933
[TBL] [Abstract][Full Text] [Related]
38. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.
Neuhauser TS; Derringer GA; Thompson LD; Fanburg-Smith JC; Miettinen M; Saaristo A; Abbondanzo SL
Mod Pathol; 2000 Sep; 13(9):978-87. PubMed ID: 11007038
[TBL] [Abstract][Full Text] [Related]
39. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Lien HC; Lin CW; Mao TL; Kuo SH; Hsiao CH; Huang CS
J Pathol; 2004 Oct; 204(2):131-9. PubMed ID: 15376261
[TBL] [Abstract][Full Text] [Related]
40. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
